Abaris Metronidazole I.V 100 ml

babies: safe if prescribed by your doctor. lactation mother: use this medication with caution during breastfeeding as it may cause side effects to the baby. pregnancy: safe if prescribed by your doctor because studies have shown evidence of no adverse effects to the developing baby. driving: avoid driving while taking this injection as it may cause dizziness, drowsiness, and sleepiness.
do not drive if these symptoms occur. alcohol: avoid driving while taking this injection as it may cause more drowsiness and liver damage.
kidney: safe if prescribed by your doctor because limited evidence is shown in patients with kidney disease. liver: use this medication with caution in patients with liver disease. dose adjustment must be necessary.
.

nausea headache dryness of mouth metallic taste .

it kills bacteria and other microorganisms that cause infection by damaging their dna..

if you miss a dose, consult your doctor and make sure it is not self-administered. .

• do not drink alcohol during or 2-3 days after treatment with this medicine. you may experience nausea, vomiting, flushing, and headache. • tell your doctor if you have liver disease.
dosage adjustment may be necessary for severe liver disease. • warn the patient to immediately report symptoms of aseptic meningitis, encephalopathy, or peripheral neuropathy. • vaginal side effects may include vaginal candidiasis, headaches, pruritis, abdominal pain, nausea, dysmenorrhea, or rash.
.

contraindicated • abaris + disulfiram: concurrent use leads to an increase the cardiac toxicity. • abaris + pimozide: concurrent use leads to increase pimozide levels by decreasing abaris. serious • abaris + axitinib: concurrent use leads to an increase in axitinib levels by decreasing abaris. • abaris + ergotamine: concurrent use leads to increase in ergotamine levels by decreasing abaris.
monitor closely • abaris + ritonavir: concurrent use leads to an increase in ritonavir levels by decreasing ritonavir. • abaris + tacrolimus: concurrent use leads to increase in tacrolimus levels by decreasing abaris. minor • abaris + dapsone: concurrent use leads to an increase in dapsone levels by decreasing abaris. • abaris + vincristine: concurrent use leads to increase in vincristine levels by decreasing abaris..